HomeAI · summaries
Storia in 9 fonti
‘No discussions’ ongoing for AstraZeneca-Bristol Myers merger: Reuters
AstraZeneca and Bristol Myers Squibb do not have any ongoing discussions about a potential deal,
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
benzinga.com
AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)
AstraZeneca in talks to merge with Bristol Myers Squibb, creating $400B pharma giant, while talks ongoing for months, antitrust scrutiny is expected.
- ·
endpoints.news
AstraZeneca, Bristol Myers are in talks about merger — report
AstraZeneca & Bristol Myers Squibb in merger talks per Financial Times. AZ worth ~$265B, BMS ~$133B. Deal may involve stock & cash; talks may not lead to deal.
